| 000 | 01534 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516113012.0 | ||
| 264 | 0 | _c20130823 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1573-2576 | ||
| 024 | 7 |
_a10.1007/s10753-012-9544-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPappas, Dimitrios A | |
| 245 | 0 | 0 |
_aAssociation of rheumatoid arthritis risk alleles with response to anti-TNF biologics: results from the CORRONA registry and meta-analysis. _h[electronic resource] |
| 260 |
_bInflammation _cApr 2013 |
||
| 300 |
_a279-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xgenetics |
| 650 | 0 | 4 |
_aCD28 Antigens _xgenetics |
| 650 | 0 | 4 |
_aChemokine CCL21 _xgenetics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aOh, Cheongeun | |
| 700 | 1 | _aPlenge, Robert M | |
| 700 | 1 | _aKremer, Joel M | |
| 700 | 1 | _aGreenberg, Jeffrey D | |
| 773 | 0 |
_tInflammation _gvol. 36 _gno. 2 _gp. 279-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10753-012-9544-4 _zAvailable from publisher's website |
| 999 |
_c22131853 _d22131853 |
||